Literature DB >> 31318608

Down-regulated RBM5 inhibits bladder cancer cell apoptosis by initiating an miR-432-5p/β-catenin feedback loop.

Yan-Ping Zhang1,2, Kai-Long Liu2, Ya-Xuan Wang2, Zhan Yang2, Zhen-Wei Han2, Bao-Sai Lu2, Jin-Chun Qi2, Yue-Wei Yin2, Zhi-Hai Teng2, Xue-Liang Chang2, Jing-Dong Li2, Hong Xin1, Wei Li2.   

Abstract

RNA-binding motif protein 5 (RBM5) acts as a tumor suppressor in various human cancers and presents with several important characteristics, such as the potentiation of apoptosis, inhibition of the cell cycle, and alternative splicing of Fas and caspase-2 precursor mRNA. However, its role in bladder urothelial carcinoma (BUC) remains unknown. In this study, we found that RBM5 expression was significantly down-regulated in BUC tissues when compared with the adjacent nontumor tissues. The down-regulation of RBM5 activates β-catenin, which binds to the T-cell factor/lymphocyte enhancer factor element of the miR-432-5p promoter and elevates the expression of miR-432-5p in bladder cancer cells. The up-regulated miR-432-5p directly targets 3'-UTR and depresses RBM5 expression. Thus, RBM5-miR-432-5p-β-catenin forms a feedback loop in regulating bladder cancer cell apoptosis. Our findings provide evidence that the regulatory feedback loop among RBM5, miR-432-5p, and Wnt-β-catenin is responsible for the progress of bladder cancer cells.-Zhang, Y.-P., Liu, K.-L., Wang, Y.-X., Yang, Z., Han, Z.-W., Lu, B.-S., Qi, J.-C., Yin, Y.-W., Teng, Z.-H., Chang, X.-L., Li, J.-D., Xin, H., Li, W. Down-regulated RBM5 inhibits bladder cancer cell apoptosis by initiating an miR-432-5p/β-catenin feedback loop.

Entities:  

Keywords:  RNA-binding motif protein 5; TCF/LEF element; bladder urothelial carcinoma; gene expression

Mesh:

Substances:

Year:  2019        PMID: 31318608     DOI: 10.1096/fj.201900537R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  6 in total

1.  Circ_0000395 Promoted CRC Progression via Elevating MYH9 Expression by Sequestering miR-432-5p.

Authors:  Leilei Fan; Weiwei Li; Hongsheng Jiang
Journal:  Biochem Genet       Date:  2022-06-27       Impact factor: 1.890

2.  Construction of an RNA-Binding Protein-Related Prognostic Model for Pancreatic Adenocarcinoma Based on TCGA and GTEx Databases.

Authors:  Xin Wen; Zhiying Shao; Shuyi Chen; Wei Wang; Yan Wang; Jinghua Jiang; Qinggong Ma; Longzhen Zhang
Journal:  Front Genet       Date:  2021-01-27       Impact factor: 4.599

3.  Alternative splicing and cancer: a systematic review.

Authors:  Yuanjiao Zhang; Jinjun Qian; Chunyan Gu; Ye Yang
Journal:  Signal Transduct Target Ther       Date:  2021-02-24

4.  MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma.

Authors:  Srinivasulu Yerukala Sathipati; Ming-Ju Tsai; Sanjay K Shukla; Shinn-Ying Ho; Yi Liu; Afshin Beheshti
Journal:  Sci Rep       Date:  2022-03-09       Impact factor: 4.379

5.  Circ_0075825 promotes gastric cancer progression via adsorbing miR-432-5p to modulate SOX9.

Authors:  He Li; Xiaohua Zhou; Zhuangming Yu; Youjing Tian
Journal:  Clinics (Sao Paulo)       Date:  2022-04-05       Impact factor: 2.365

6.  MicroRNA-432 Suppresses Invasion and Migration via E2F3 in Nasopharyngeal Carcinoma.

Authors:  Tingting Wang; Mingyu Du; Wenjun Zhang; Hui Bai; Li Yin; Wei Chen; Xia He; Qi Chen
Journal:  Onco Targets Ther       Date:  2019-12-19       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.